Isolation and characterization of natural human IgG with a morphine-like activity

European Journal of Immunology

Volumn 29, Issue 3, 1999, Pages 997-1003

  Macé, Gaëtane ^a   Blanpied, Catherine ^a   Emorine, Laurent J ^b   Druet, Philippe ^a   Dietrich, Gilles ^a  

^a CHU PURPAN   (France)

^b CNRS   (France)

Author keywords

Autoantibody; Autoimmunity; mu opioid receptor; Opioid

Indexed keywords

ADENYLATE CYCLASE; AUTOANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MORPHINE; MU OPIATE RECEPTOR; OPIATE ANTAGONIST; PERTUSSIS TOXIN;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; CYTOFLUOROMETRY; ENZYME INHIBITION; FEMALE; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; RECEPTOR AFFINITY;

EID: 0033025730     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199903)29:03<997::AID-IMMU997>3.0.CO;2-1     Document Type: Article

References (13)

1. Straub, R. H., Westermann, J., Schölmerich, J. and Falk, W., Dialogue between the CNS and the immune system in lymphoid organs. Immunol. Today 1998. 19: 409-413.
2. Stein, C., The control of pain in peripheral tissue by opioids. N. Engl. J. Med. 1995. 332: 1685-1690.
3. Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., Tzavara, E., Hanoune, J., Roques, B. P. and Kieffer, B. L., Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene. Nature 1996. 383: 819-823.
4. Avrameas, S. and Ternynck, T., Natural autoantibodies: the other side of the immune system. Res. Immunol. 1995. 146: 235-248.
5. Sibinga, N. E. S. and Goldstein, A., Opioid peptides and opioid receptors in cells of the immune system. Annu. Rev. Immunol. 1988. 6: 219-249.
6. Tian, M., Broxmeyer, H. E., Fan, Y., Lai, Z., Zhang, S., Aronica, S., Cooper, S., Bigsby, R. M., Steinmetz, R., Engle, S. J., Mestek, A., Pollock, J. D., Lehman, M. N., Jansen, H. T., Ying, M., Stambrook, P. J., Tischfield, J. A. and Yu, L., Altered hematopoiesis, behavior, and sexual function in μ opioid receptor-deficient mice. J. Exp. Med. 1997. 185: 1517-1522.
7. Grimm, M. C., Ben-Baruch, A., Taub, D. D., Howard, O. M. Z., Resau, J. H., Wang, J. M., Ali, H., Richardson, R., Snyderman, R. and Oppenheim, J. J., Opiates transdeactivate chemokine receptors: δ and μ opiate receptor-mediated heterologuous desensitization. J. Exp. Med. 1998. 188: 317-325.
8. Johnson, H. M., Smith, E. M., Torres, B. A. and Blalock, J. E., Regulation of the in vitro antibody response by neuroendocrine hormones. Proc. Natl. Acad. Sci. USA 1982. 79: 4171-4174.
9. Barcellini, W., Rizzardi, G. P., Velati, C., Borghi, M. O., Fain, C., Lazzarin, A. and Meroni, P. L., In vitro production of type 1 and type 2 cytokines by peripheral blood mononuclear cells from high-risk HIV-negative intravenous drug users. AIDS 1995. 9: 691-694.
10. Dwyer, J. M., Manipulating the immune system with immune globulin. N. Engl. J. Med. 1992. 326: 107-116.
11. Saoudi, A., Hurez, V., de Kozak, Y., Kuhn, J., Kaveri, S. V., Kazatchkine, M. D., Druet, P. and Bellon, B., Human immunoglobulin preparations for intravenous use (IVIg) prevent experimental autoimmune uveoretinitis. Int. Immunol. 1993. 5: 1559-1567.
12. Gaibelet, G., Capeyrou, R., Dietrich, G. and Emorine, L. J., Identification in the μ-opioid receptor of cysteine residues responsible for inactivation of ligand binding by thiol alkylating and reducing agents. FEBS Lett. 1997. 408: 135-140.
13. Druet, E., Praddaude, F., Druet, P. and Dietrich, G., Non-Ig serum proteins prevent the binding of IgG from normal rats and from rats with Th2-mediated autoimmune glomerulonephritis to various autoantigens including glomerular antigens. Eur. J. Immunol. 1998. 28: 183-192.